When treating patients who may be eligible for hematopoietic cell transplant, you can find links here to:
On this page:
Over the last decade, hematopoietic cell transplantation (HCT, also known as BMT) has become a standard of care for some diseases and a newer treatment option for others. Research and resulting studies have led to expanded patient selection, more precise HLA matching between donor and patient, and more preventive strategies and improved management of complications during patient recovery and survivorship.
To clarify when a patient may need a transplant, guidelines were developed jointly by the National Marrow Donor Program® (NMDP) and the American Society for Blood and Marrow Transplantation (ASBMT). These guidelines are based upon current clinical practice and the medical literature.
If an unrelated hematopoietic cell transplant is a treatment option for a patient, any physician may request a free preliminary search of the registry. The registry of the C.W. Bill Young Cell Transplantation Program, also called the Be The Match Registry®, is a listing of potential marrow donors and donated cord blood units. The registry is operated by the NMDP, which operates Be The Match, under Federal contracts.
A preliminary search lists potentially matched marrow donors or cord blood units at a single moment in time. It does not begin contact with, or request additional testing of, a potential marrow donor or cord blood unit. A preliminary search can be done early, while developing a treatment plan or initiating other treatment.
You can also immediately see how many potential donors and cord blood units on the registry may match your patient using the MatchView® resource.
A variety of medical education opportunities on the current state of the art in hematopoietic cell transplantation are available.
Refer families who have a medical need.